Adenovirus-mediated urokinase gene transfer induces liver regeneration and allows for efficient retrovirus transduction of hepatocytes in vivo.

AUTOR(ES)

Lieber, A

RESUMO

Retrovirus-mediated gene transfer into hepatocytes in vivo results in long-term gene expression. Limitations include the need to remove two-thirds of the liver and the relatively low frequency of gene transfer. To increase gene transfer without surgical hepatectomy, mouse hepatocytes were transduced in vivo with a recombinant adenovirus that transiently expressed urokinase, resulting in high rates of asynchronous liver regeneration. During the regenerative phase, in vivo retroviral-mediated gene transfer in hepatocytes resulted in 5- to 10-fold greater transduction efficiencies than that obtained by conventional partial hepatectomy. In 3-4 weeks, the architecture and microscopic structure of the recipient livers were normal. The two-viral system of achieving permanent transgene expression from hepatocytes in vivo offers an alternative approach to current ex vivo and in vivo gene-transfer models.

Documentos Relacionados

• Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo.
• Adenovirus-mediated transfer of the HST-1 (FGF4) gene induces increased levels of platelet count in vivo.
• Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer.
• Canine Adenovirus Vectors: an Alternative for Adenovirus-Mediated Gene Transfer
• Adenovirus-mediated regulable target gene expression in vivo